PHENTERMINE RESIN 30 Drug Patent Profile
✉ Email this page to a colleague
When do Phentermine Resin 30 patents expire, and when can generic versions of Phentermine Resin 30 launch?
Phentermine Resin 30 is a drug marketed by Quantum Pharmics and is included in one NDA.
The generic ingredient in PHENTERMINE RESIN 30 is phentermine resin complex. There are seventeen drug master file entries for this compound. Additional details are available on the phentermine resin complex profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHENTERMINE RESIN 30?
- What are the global sales for PHENTERMINE RESIN 30?
- What is Average Wholesale Price for PHENTERMINE RESIN 30?
Summary for PHENTERMINE RESIN 30
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 29 |
| Clinical Trials: | 47 |
| DailyMed Link: | PHENTERMINE RESIN 30 at DailyMed |
Recent Clinical Trials for PHENTERMINE RESIN 30
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| HealthPartners Institute | Phase 4 |
| The University of Texas Health Science Center, Houston | Phase 4 |
| Kaiser Permanente | Phase 4 |
US Patents and Regulatory Information for PHENTERMINE RESIN 30
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quantum Pharmics | PHENTERMINE RESIN 30 | phentermine resin complex | CAPSULE, EXTENDED RELEASE;ORAL | 089120-001 | Feb 4, 1988 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
